Geri
AKADEMİK

(Liste, ünvan ve isme göre alfabetik olarak sıralanmıştır.)

Kurum İçi Görevlendirme

text
Adı Soyadı Prof.Dr. Ertuğrul KILIÇ
E-Posta [email protected]
Detay Öz Geçmiş
Medya

Daha Önce Görev Yaptığı Yerler

Araştırma Alanları

Beyin Felci; Nörobiyoloji

Seçili Yayınları / Tüm Yayınları

1. Elibol-Can B, Kilic E, Yuruker S, Jakubowska-Dogru E. Investigation into the effects of prenatal alcohol exposure on postnatal spine development andexpression of synaptophysin and PSD95 in rat hippocampus. Int J Dev Neurosci. 2014;33:106-14. doi: 10.1016/j.ijdevneu.2013.12.003. Epub 2013 Dec 21.

2. Elibol-Can B, Dursun I, Telkes I, Kilic E, Canan S, Jakubowska-Dogru E. Examination of Age- dependent effects of fetal ethanol exposure on behavior, hippocampal cellcounts, and doublecortin immunoreactivity in rats. Dev Neurobiol. 2013 Oct 29. doi: 10.1002/dneu.22143. [Epub ahead of print]

3. Karadeli HH, Aktekin B, Yilmaz B, Kilic E, Uzar E, Aci A, Bingol CA. Effects of melatonin on behavioral changes of neonatal rats in a model of cortical dysplasia. Eur Rev Med Pharmacol Sci. 2013 ;17(15):2080-4

4. Sehirli AO, Koyun D, Tetik S, Ozsavcı D, Yiğiner O, Cetinel S, Tok OE, Kaya Z, Akkiprik M, Kilic E, Sener G. Melatonin protects against ischemic heart failure in rats. J Pineal Res. (2013) 55(2):138-48

5. Kilic U, Yilmaz B, Reiter RJ, Yüksel A, Kilic E. Effects of memantine and melatonin on signal transduction pathways vascular leakage and brain injury after focal cerebral ischemia in mice. Neuroscience. (2013) May 1;237:268-76

6. Kilic U, Kilic E, Tuzcu Z, Tuzcu M, Ozercan IH, Yilmaz O, Sahin F, Sahin K. Melatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf-2/HO-1 pathway. Nutr Metab (Lond). (2013) 12;10(1):7

7. Kilic U, Yilmaz B, Ugur M, Yüksel A, Reiter RJ, Hermann DM, Kilic E. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia (2012) Journal of Pineal Research, 52: 228-35. (I.F.: 5.85)

8. Kelestemur S, Kilic E, Uslu U, Cumbul A, Ugur M, Akman S, Culha M. Wound Healing Properties of Modified Silver Nanoparticles and their Distribution in Mouse Organs after Topical Application. (2012) Nano Biomedicine and Engineering, 4: 170-176.

9. Herz J, Reitmeir R, Hagen SI, Reinboth BS, Guo Z, Zechariah A, Elali A, Doeppner TR, Bacigaluppi M, Pluchino S, Kilic U, Kilic E, Hermann DM.Intracerebroventricularly delivered VEGF promotes contralesional corticorubral plasticity after focal cerebral ischemia via mechanisms involving anti-inflammatory actions. (2012) Neurobiology of Diseases, 45:1077-85 (I.F.: 4.9)

10. Reitmeir R, Kilic E, Reinboth BS, Guo Z, ElAli A, Zechariah A, Kilic U, Hermann DM. Vascular endothelial growth factor induces contralesional corticobulbar plasticity and functional neurological recovery in the ischemic brain.. (2012) Acta Neuropathologica. 123: 273-84 (I.F.: 7.5)

11. Mete F, Kilic E, Somay A, Yilmaz B. Effects of heat stress on endocrine functions & behaviour in the pre-pubertal rat. Indian J Med Res. 2012;135:233-9.

12. Reitmeir R., Kilic E, Kilic U, Bacigaluppi, M, ElAli A, Salani G, Pluchino S, Gassmann M, Hermann DM. Post-acute delivery of erythropoietin induces stroke recovery by promoting perilesional tissue remodeling and contralesional pyramidal tract plasticity. (2011) Brain, 134:84-99 (I.F.: 9.603)

13. Kilic E, Elali A, Kilic U, Guo Z, Ugur M, Uslu U, Bassetti CL, Hermann DM. Role of Nogo-A in neuronal survival in the reperfused ischemic brain (2010) Journal of Cerebral Blood Flow and Metabolism, 30 (5), pp. 969-984. (I.F.: 5.741)

14. Tug, N., Kilic, U., Karateke, A., Yilmaz, B., Ugur, M., Kilic, E. Erythropoietin receptor-like immunostaining on human spermatozoa. (2010) Reproductive BioMedicine Online 21 (5):718-720. (I.F.: 2.380)

15. Yulug B, Erkol G, Kilic E. An interesting link between microgravity and psychiatric diseases. (2010) J Neuropsychiatry Clin Neurosci. 22: 451-g.e12-451.e12. . (I.F.: 2.362)

16. Yulug B, Ozan E, Kilic E. Brain-derived neurotrophic factor polymorphism as a genetic risk for depression? A short review of the literature. (2010) J Neuropsychiatry Clin Neurosci. Winter;22(1):123d.e5-123.e6

17. Muammer R, Kilic E, Hayran O. The effect of physiotherapy treatment on saliva decrease in children with cerebral palsy. Indian Journal of Physiotherapy and Occupational Therapy—An International Journal. (2010) 4: 129-131

18. Sahin K, Akdemir F, Tuzcu M, Sahin N, Onderci M, Ozercan R, Ilhan N, Kilic E, Seren S, Kucuk O. Genistein suppresses spontaneous oviduct tumorigenesis in quail. (2009) Nutr Cancer. 2009 Nov;61(6):799-806. (I.F.: 2.360)

19. Yalvac, M.E., Rizvanov, A.A., Kilic, E., Sahin, F., Mukhamedyarov, M.A., Islamov, R.R., Palotás, A. Potential role of dental stem cells in the cellular therapy of cerebral ischemia (2009) Current Pharmaceutical Design, 15 (33), pp. 3908-3916. (I.F.: 4.399)

20. Yulug B, Kilic E. Olanzapine does not aggrevate ischemic neuronal injury by focal cerebral ischemia: A dose related restriction of the neuroprotective effect? (2009) Medicinal Chemistry, 5 (3), pp. 279-282. (I.F.: 2.362)

21. Bacigaluppi M, Pluchino S, Peruzzotti-Jametti L, Kilic E, Kilic U, Salani G, Brambilla E, West MJ, Comi G, Martino G, Hermann DM. Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms (2009) Brain, 132 (8), pp. 2239-2251. (I.F.: 9.603)

22. Aydin O. Kahraman M. Kilic E. Çulha M. Surface-enhanced raman scattering of rat tissues (2009) Applied Spectroscopy, 63 (6), pp. 662-668. (I.F.: 2.062)

23. Yildirim G, Attar R, Ficicioglu C, Karateke A, Ozkan F, Kilic E, Yilmaz B, Yesildaglar N. Kombine letrozol ve melatonin tedavisinin deneysel rat endometriosis modelinde lezyon boyutları ve histopatolojik skorlar üzerine etkisi J Turkish German Gynecol Assoc. Year: 2009 Volume: 10 Issue: 4 199-204

24. Yulug B, Ozan E, Gönül AS, Kilic E. Brain-derived neurotrophic factor, stress and depression: A minireview (2009) Brain Research Bulletin, 78 (6), pp. 267-269. (I.F.: 2.281) X

25. Hermann DM, Kilic E. Therapeutic potential and possible risks of pleiotropic growth factors in ischemic stroke (2008) Stroke, 39 (11), p. e182. (I.F.: 6.499)

26. Cam E, Yulug B, Cengiz N, Poelkin E, Isik D, Bakar M, Ozan E, Kilic E. Melatonin: A suitable agent for depression associated with stroke? (2008) Journal of Neuropsychiatry and Clinical Neurosciences, 20 (4), pp. 498-500. (I.F.: 2.362)

27. Kilic E, Hermann DM, Spudich A, Kilic Ü, Rentsch KM, Vig R, Matter CM, Bassetti CL. ABCC1: A gateway for pharmacological compounds to the ischaemic brain (2008) Brain, 131 (10), pp. 2679-2689. (I.F.: 9.603)

28. Gao B, Kilic E, Baumann CR, Hermann DM, Bassetti CL. Gamma-hydroxybutyrate accelerates functional recovery after focal cerebral ischemia (2008) Cerebrovascular Diseases, 26 (4), pp. 413-419. (I.F.: 3.041)

29. Kilic E, Kilic U, Bacigaluppi M, Guo Z, Abdallah NB, Wolfer DP, Reiter RJ, Bassetti CL. Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice (2008) Journal of Pineal Research, 45 (2), pp. 142-148. (I.F.: 5.056)

30. Kilic U, Kilic E, Matter CM, Bassetti CL, Hermann DM. TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration (2008) Neurobiology of Disease, 31 (1), pp. 33-40. (I.F.: 4.852)

31. Bacigaluppi M, Pluchino S, Martino G, Kilic E, Hermann DM. Neural stem/precursor cells for the treatment of ischemic stroke (2008) Journal of the Neurological Sciences, 265 (1-2), pp. 73-77. (I.F.: 2.359)

32. Hédou GF, Koshibu K, Farinelli M, Kilic E, Gee CE, Kilic U, Baumgärtel K, Mansuy IM. Protein phosphatase 1-dependent bidirectional synaptic plasticity controls ischemic recovery in the adult brain (2008) Journal of Neuroscience, 28 (1), pp. 154-162. (I.F.: 7.452)

33. Kilic E, Hermann DM, Wippel A, Kilic Ü, Vogel P, Kim M, van der Putten H, Böttiger BW. Poxvirus-derived cytokine response modifier A (CrmA) does not protect against focal cerebral ischemia in mice (2007) Brain Research, 1185 (1), pp. 293-300. (I.F.: 2.494)

34. Yulug B, Cam E, Yildiz A, Kilic E. Buprenorphine does not aggrevate ischemic neuronal injury in experimental focal cerebral ischemia (2007) Journal of Neuropsychiatry and Clinical Neurosciences, 19 (3), pp. 331-334. (I.F.: 2.362)

35. Kilic Ü, Hermann DM, Kilic E, Järve, A, Guo, Z, Spudich, A, Bieber, K, Marti HH. Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways (2006) Journal of Neuroscience, 26 (48), pp. 12439-12446. (I.F.: 7.452)

36. Hermann DM, Kilic E, Spudich A, Krämer SD, Wunderli-Allenspach H, Bassetti CL. Role of drug efflux carriers in the healthy and diseased brain (2006) Annals of Neurology, 60 (5), pp. 489-498. (I.F.: 9.935)

37. Baumann CR, Kilic E, Petit B, Werth E, Hermann DM, Tafti M, Bassetti CL. Sleep EEG changes after middle cerebral artery infarcts in mice: Different effects of striatal and cortical lesions (2006) Sleep, 29 (10), pp. 1339-1344. (I.F.: 4.475)

38. Kilic E, Kilic Ü, Wang Y, Bassetti CL, Marti HH, Hermann DM. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia (2006) FASEB Journal, 20 (8), pp. E307-E314. (I.F.: 7.049)

39. Kilic E, Kilic U, Wang Y, Bassetti CL, Marti HH, Hermann DM. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. (2006) The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 20 (8), pp. 1185-1187. (I.F.: 7.049)

40. Yulug B, Yildiz A, Güzel O, Kilic E, Schäbitz WR, Kilic E. Risperidone attenuates brain damage after focal cerebral ischemia in vivo (2006) Brain Research Bulletin, 69 (6), pp. 656-659. (I.F.:2.281)

41. Spudich A, Kilic E, Xing H, Kilic Ü, Rentsch KM, Wunderli-Allenspach H, Bassetti CL, Hermann DM. Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia (2006) Nature Neuroscience, 9 (4), pp. 487-488. (I.F.: 14.164)

42. Kilic E, Kilic U, Hermann DM. TAT fusion proteins against ischemic stroke: Current status and future perspectives (2006) Frontiers in Bioscience, 11 (2), pp. 1716-1721. (I.F.: 3.308)

43. Kilic E, Kilic Ü, Soliz J, Bassetti CL, Gassmaim M, Hermann DM. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways (2005) FASEB Journal, 19 (14), pp. 2026-2028. (I.F.: 7.049)

44. Kilic, E, Kilic Ü, Hermann DM. TAT-GDNF in neurodegeneration and ischemic stroke (2005) CNS Drug Reviews, 11 (4), pp. 369-378. (I.F.: 4.432)

45. Kilic E, Kilic Ü, Bähr M, Hermann DM. Tissue plasminogen activator-induced ischemic injury is reversed by NMDA antagonist MK-801 in vivo (2005) Neurodegenerative Diseases, 2 (2), pp. 49-55. (I.F.: 2.989)

46. Spudich A, Frigg R, Kilic E, Kilic U, Oesch B, Raeber A, Bassetti CL, Hermann DM. Aggravation of ischemic brain injury by prion protein deficiency: Role of ERK-1/-2 and STAT-1 (2005) Neurobiology of Disease, 20 (2), pp. 442-449. (I.F.: 4.852)

47. Kilic E, Kilic Ü, Reiter RJ, Bassetti CL, Hermann DM. Tissue-plasminogen activator-induced ischemic brain injury is reversed by melatonin: Role of iNOS and Akt (2005) Journal of Pineal Research, 39 (2), pp. 151-155. (I.F.: 5.056)

48. Kilic Ü, Bassetti CL, Kilic E, Xing H, Wang Z, Hermann DM. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2 (2005) Neuroscience, 134 (3), pp. 901-906. (I.F.: 3.556)

49. Grimm C, Hermann DM, Bogdanova A, Hotop S, Kilic Ü, Wenzel A, Kilic E, Gassmann M. Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration (2005) Seminars in Cell and Developmental Biology, 16 (4-5), pp. 531-538. (I.F.: 4.528)

50. Reiter RJ, Tan DX, Leon J, Kilic Ü, Kilic E. When melatonin gets on your nerves: Its beneficial actions in experimental models of stroke (2005) Experimental Biology and Medicine, 230 (2), pp. 104-117. (I.F.: 2.202)

51. Kilic Ü, Kilic E, Soliz J, Bassetti CL, Gassmann M, Hermann DM. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2 (2005) FASEB Journal, 19 (2), pp. 249-251. (I.F.: 7.049)

52. Kilic E, Kilic Ü, Matter CM, Lüscher TF, Bassetti CL, Hermann DM. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase (2005) Stroke, 36 (2), pp. 332-336. (I.F.: 6.499)

53. Kilic Ü, Kilic E, Reiter RJ, Bassetti CL, Hermann DM. Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice (2005) Journal of Pineal Research, 38 (1), pp. 67-71. (I.F.: 5.056)

54. Wang Y, Kilic E, Kilic Ü, Weber B, Bassetti CL, Marti HH, Hermann DM. VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena (2005) Brain, 128 (1), pp. 52-63. (I.F.: 9.603)

55. Kilic E, Kilic Ü, Reiter RJ, Bassetti CL, Hermann DM. Prophylactic use of melatonin protects against focal cerebral ischemia in mice: Role of endothelin converting enzyme-1 (2004) Journal of Pineal Research, 37 (4), pp. 247-251. (I.F.: 5.056)

56. Kilic E, Weishaupt JH, Kilic Ü, Rohde G, Yulug B, Peters K, Hermann DM, Bähr M. The superoxide dismutase1 (SOD1) G93A mutation does not promote neuronal injury after focal brain ischemia and optic nerve transection in mice (2004) Neuroscience, 128 (2), pp. 359-364. (I.F.: 3.556)

57. Reiter RJ, Kilic Ü, Tan DX, Gitto E, Sainz RM, Mayo JC, Leon J, Kilic E. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage (2004) Polish Journal of Pharmacology, 56 (2), pp. 159-170. (I.F.: 2.167, The Pharmacological Reports)

58. Kilic Ü, Kilic E, Lingor P, Yulug B, Bähr M. Rifampicin inhibits neurodegeneration in the optic nerve transection model in vivo and after 1-methyl-4-phenylpyridinium intoxication in vitro (2004) Acta Neuropathologica, 108 (1), pp. 65-68. (I.F.: 5.310)

59. Kilic Ü, Kilic E, Dietz GPH, Bähr M. The TAT protein transduction domain enhances the neuroprotective effect of glial-cell-line-derived neurotrophic factor after optic nerve transection (2004) Neurodegenerative Diseases, 1 (1), pp. 44-49. (I.F.: 2.989)

60. Kilic E, Kilic Ü, Yulug B, Hermann DM, Reiter RJ. Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase-3 and is suitable as an add-on treatment to tissue-plasminogen activator (2004) Journal of Pineal Research, 36 (3), pp. 171-176. (I.F.: 5.056)

61. Kilic E, Kilic Ü, Bassetti CL, Hermann DM. Intravenously administered recombinant tissue-plasminogen activator attenuates neuronal injury after mild focal cerebral ischemia in mice (2004) NeuroReport, 15 (4), pp. 687-689. (I.F.: 1.904)

62. Yulug B, Kilic U, Kilic E, Bähr M. Rifampicin attenuates brain damage in focal ischemia (2004) Brain Research, 996 (1), pp. 76-80. (I.F.: 2.494)

63. Kilic Ü, Kilic E, Dietz GPH, Bähr M. Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice (2003) Stroke, 34 (5), pp. 1304-1310. (I.F.: 6.499)

64. Kügler S, Kilic E, Bähr M. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area (2003) Gene Therapy, 10 (4), pp. 337-347. (I.F.: 4.492)

65. Kilic E, Hermann DM, Kügler S, Kilic Ü, Holzmüller H, Schmeer C, Bähr M. Adenovirus-mediated Bcl-XL expression using a neuron-specific synapsin-1 promoter protects against disseminated neuronal injury and brain infarction following focal cerebral ischemia in mice (2002) Neurobiology of Disease, 11 (2), pp. 275-284. (I.F.: 4.852)

66. Kilic E, Dietz GPH, Hermann DM, Bähr M. Intravenous TAT-Bcl-XL is protective after middle cerebral artery occlusion in mice (2002) Annals of Neurology, 52 (5), pp. 617-622. (I.F.: 9.935)

67. Dietz GPH, Kilic E, Bähr M. Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction (2002) Molecular and Cellular Neuroscience, 21(1), pp. 29-37. (I.F.: 3.934)

68. Kilic E, Hermann DM, Isenmann S, Bähr M. Effects of pinealectomy and melatonin on the retrograde degeneration of retinal ganglion cells in a novel model of intraorbital optic nerve transection in mice (2002) Journal of Pineal Research, 32 (2), pp. 106-111. (I.F.: 5.056)

69. Hermann DM, Kilic E, Kügler S, Isenmann S, Bähr M. Adenovirus-mediated glial cell line-derived neurotrophic factor (GDNF) expression protects against subsequent cortical cold injury in rats (2001) Neurobiology of Disease, 8 (6), pp. 964-973. (I.F.: 4.852)

70. Kilic E, Bähr M, Hermann DM. Effects of recombinant tissue plasminogen activator after intraluminal thread occlusion in mice: Role of hemodynamic alterations (2001) Stroke, 32 (11), pp. 2641-2647. (I.F.: 6.499)

71. Dietz GPH, Kilic E, Bähr M, Isenmann S. Bcl-2 is not required in retinal ganglion cells surviving optic nerve axotomy (2001) NeuroReport, 12 (15), pp. 3353-3356. (I.F.: 1.904)

72. Hermann DM, Kilic E, Kügler S, Isenmann S, Bähr M. Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice (2001) Neurobiology of Disease, 8 (4), pp. 655-666. (I.F.: 4.852)

73. Knöll B, Isenmann S, Kilic E, Walkenhorst J, Engel S, Wehinger J, Bähr M, Drescher U. Graded expression patterns of ephrin-As in the superior colliculus after lesion of the adult mouse optic nerve (2001) Mechanisms of Development, 106 (1-2), pp. 119-127. (I.F.: 2.534)

74. Hermann DM, Kilic E, Hata R, Hossmann K-A, Mies G. Relationship between metabolic dysfunctions, gene responses and delayed cell death after mild focal cerebral ischemia in mice (2001) Neuroscience, 104 (4), pp. 947-955. (I.F.: 3.556)

75. Sönmez AS, Birincio?lu M, Aydin A, Kiliç E, Şahin N. Effects of misoprostol on the endometrium of ovariectomized rats (2000) Turkish Journal of Medical Sciences, 30(2),pp. 115-118.

76. Kilic E, Hermann DM, Hossmann KA. Recombinant tissue-plasminogen adivator-induced thrombolysis after cerebral thromboembolism in mice (2000) Acta Neuropathologica, 99 (3), pp. 219-222. (I.F.: 5.310)

77. Kilic E, Özdemir YG, Bolay H, Keleştimur H, Dalkara T. Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia (1999) Journal of Cerebral Blood Flow and Metabolism, 19 (5), pp. 511-516. (I.F.: 5.741)

78. Kilic E, Hermann DM, Hossmann KA. Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice
(1999) NeuroReport, 10 (1), pp. 107-111. (I.F.: 1.904)

79. Kilic E, Hermann DM, Hossmann KA. A reproducible model of thromboembolic stroke in mice (1998) NeuroReport, 9 (13), pp. 2967-2970. (I.F.: 1.904)








text
Adı Soyadı Dr.Öğr.Üye. Pakize YİĞİT
E-Posta [email protected]
Detay Öz Geçmiş
Medya

Yıldız Teknik Üniversitesi 2007 İstanbul Üniversitesi Sayısal Yöntemler BD

Daha Önce Görev Yaptığı Yerler

Araştırma Alanları

istatistik, veri madenciliği

Seçili Yayınları / Tüm Yayınları

text
Adı Soyadı Dr.Öğr.Üye. Ayşe Arzu ŞAKUL
E-Posta [email protected]
Detay Öz Geçmiş
Medya

Ondokuzmayıs Üniversitesi 1994 Hacettepe Üniversitesi Tıp Fakültesi & Gazi Üniversitesi Tıp Fakültesi

Daha Önce Görev Yaptığı Yerler

Sağlık Bakanlığı-Acil Sağlık Hizmetleri Genel Müdürlüğü- Afet ve Acil Durum Daire Başkanlığı- Ulusal Zehir Merkezi Koordinatörü

Araştırma Alanları

Diabetes Mellitus, oksidatif ve nitrozatif stres, senescence ve rejenerasyon, bağımlılık farmakolojisi, klinik toksikoloji, klinik farmakoloji, nörofarmakoloji

Seçili Yayınları / Tüm Yayınları

Kurum Dışı Görevlendirme